Microbial Diseases, Royal Free Campus,University College London, London, NW3 2PF
Dedicated to improving oral and gastrointestinal health
INFLAMMATORY BOWEL DISEASE
Crohn's disease and ulcerative colitis
Background
Inflammatory bowel disease (IBD)
​
Inflammatory bowel disease (IBD) is an umbrella term used to describe disorders that cause chronic inflammation of your gastrointestinal (GI) tract. The two most common forms of IBD are Crohn’s disease and ulcerative colitis.
​
​
Crohn’s disease (CD) is a chronic, relapsing-remitting gastrointestinal condition. It can affect any part of the GI tract, as well as causing extraintestinal manifestations in the hepato-pancreato-biliary system, skin, joints, eyes, oral cavity and bone metabolism. It affects approximately 1 in 800 people in the UK and its incidence is rising globally.
CD is a multifactorial immune-mediated disease, causing transmural inflammation of the GI tract. The aetiological factors that cause CD are still not fully elucidated, but genetics, alterations in gut microbiota and environmental factors are known to play a role.
In the first 5 years from diagnosis 22% of patients will require surgical intervention, rising to 70-90% during their lifetime. However, risk of surgical, endoscopic and clinical recurrence remains high. It is estimated that up to 40% of patients will have surgical recurrence within 10 years. Surgical intervention may be necessary to manage strictures, fistulae, obstruction or perforation, but is not curative.
​
Ulcerative colitis (UC) is a chronic, relapsing-remitting gastrointestinal condition. It mainly affects the large intestine, also known as the colon, resulting in extensive inflammation of the GI lining and ulcer formation. The disease affects approximately 1 in 1000 of the population.
The pathogenesis of UC is complex and is classically thought to involve an abnormal interaction between the microbial flora, mucosal epithelial barrier, and the host immune system in susceptible individuals.
UC typically starts in the rectum and extends proximally in a uniform manner resulting in the 3 major phenotype classifications of proctitis, left-sided, or pancolitis. Twenty to 54% of patients develop a more extensive phenotype over the course of their disease. Primary defects of the mucosa have been postulated as being important in the etiology of the disease.
​
Current Research in IBD
1
Treatment outcome in Crohn's disease
This clinical observational study will consider the role of genetics, the microbiome and malnutrition in relation to Crohn's Disease treatment outcomes across multiple NHS hospitals. Each patient included in the study will be followed for two years. We hope to improve the identification of patients at risk of undesirable treatment outcomes and support the development of improved treatment protocols for these patients.
Recent publication
Sarcopenia is associated with increased rates of infectious post-operative complications in Crohn’s disease patients.
​
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i639–i640,
2
Development of patient derived gut organoids
This study aims to:
-
Develop a novel laboratory model of gastrointestinal inflammation using a multicellular organoid system generated from biopsies and blood taken from patients with Inflammatory Bowel Disease (IBD).
-
Uncover the mechanistic impact of key IBD-associated gene variants and their effect on immune signalling and inflammasome regulation at a single-cell resolution.
​
The projects is in collaboration with Dr Chris Tape UCL Cancer Institute
3
Studying the oral gut axis and its relationship to IBD
This project brings together a team of experts in the fields of gastroenterology, periodontology, immunology and microbiology to study the oral-gut axis and its association with IBD and oral inflammatory diseases.
Recent publication
Adalimumab in Crohn’s disease is protective against periodontitis based on a validated oral health questionnaire.
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i383–i385